Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a genetically engineered mouse model of pancreatic cancer. - Wikidata - awgldk - TriplyDB

Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a genetically engineered mouse model of pancreatic cancer.

Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a genetically engineered mouse model of pancreatic cancer.

http://www.wikidata.org/entity/Q34346758

about

Dynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironment Evaluation of Efficacy of Radioimmunotherapy with 90Y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models.Idiopathic pancreatitis in a patient with a STAT3 mutation.Histone deacetylase inhibitors provoke a tumor supportive phenotype in pancreatic cancer associated fibroblasts.A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy.

P2860

Q27025321-2F5DAAC4-4AA4-4FF0-A029-3220C832946F Q35499776-3A0A212E-8708-4AB7-BD88-8A81EDD17793 Q36814154-C427CDDA-0E28-4B32-9187-A4E3A5752FD9 Q37745937-0A4D9CE9-8685-461F-AD15-6C66936B4369 Q40766189-6E3FD569-9D23-400C-A987-8D7C34FB69EF

P2860

Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a genetically engineered mouse model of pancreatic cancer.

http://www.wikidata.org/entity/Q34346758

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Chronic pancreatitis and syste ...... se model of pancreatic cancer.

@ast

Chronic pancreatitis and syste ...... se model of pancreatic cancer.

@en

Chronic pancreatitis and syste ...... se model of pancreatic cancer.

@nl

type

label

Chronic pancreatitis and syste ...... se model of pancreatic cancer.

@ast

Chronic pancreatitis and syste ...... se model of pancreatic cancer.

@en

Chronic pancreatitis and syste ...... se model of pancreatic cancer.

@nl

prefLabel

Chronic pancreatitis and syste ...... se model of pancreatic cancer.

@ast

Chronic pancreatitis and syste ...... se model of pancreatic cancer.

@en

Chronic pancreatitis and syste ...... se model of pancreatic cancer.

@nl

P1433

Q34346758-BE6FD738-6569-4D59-A03C-1F18444D2855

P1476

Q34346758-B2731757-8688-4C17-A2BC-AEC9153334C6

P2093

Q34346758-10937812-CD29-4C33-AC31-996F740D2A38

Q34346758-79435EF2-DC8F-4829-9E32-BA21C61DB0B7

Q34346758-B738D606-7BA4-48A2-A7F7-02B15212B9A1

Q34346758-C64721E7-9865-4F2E-863B-F6C480D62781

Q34346758-CC7D856C-18DD-4EFA-9214-8A97109D5125

Q34346758-E9172124-EBDA-4B60-B8DC-23D716A5E62B

Q34346758-F37A4459-A944-4157-B611-79DCFD781573

P2860

Q34346758-0514E362-B722-4791-AB74-D8A84999F3E2

Q34346758-0FC3FB59-E1CC-40BE-ADFE-1FB23F50837C

Q34346758-13702E8E-2561-481E-A891-8A6FE8CF8018

Q34346758-1CEC2038-BAE6-4343-845A-198563E750AA

Q34346758-29451404-7AE0-423A-A9EF-61AA2D0672BE

Q34346758-3457C363-604B-48A5-8106-F3EB880906E3

Q34346758-480A8972-0F9D-4929-8A6A-6B1E0AB580FD

Q34346758-5F5DA807-F595-4408-B09D-745A4A203664

Q34346758-611759D6-A23F-4AB7-B0D1-13343046BAD6

Q34346758-68E66228-6C0A-4195-9E73-04FF1D63E3C8

P304

Q34346758-BF2B8F5D-D3F4-42C8-B5C0-D452E596DFAD

P31

Q34346758-0D8F77A3-FD9B-4C2A-B4A9-329908638CFA

P356

Q34346758-D5656BF2-4B89-4A03-8330-3F739C09DEBF

P433

Q34346758-855659AB-4D4C-43D2-BD58-3D4BBA369F55

P478

Q34346758-7BF5177A-09A4-4837-8A60-71A754EBBF7B

P50

Q34346758-C662A955-7F19-420D-AD43-92064017BCB2

P577

Q34346758-3C304C85-D4CE-446B-B676-C48BE682D926

P5875

Q34346758-012F3882-4612-4419-8C07-5CC06430F908

P698

Q34346758-47F019AE-BD34-4870-9336-1FE27F00A89D

P921

Q34346758-6FD9722B-08A0-46BF-A917-9819E75493A3

P932

Q34346758-D5CF03DC-7517-4ADD-9574-9CB9CACC955F

P356

J.NEO.2014.05.010

P1433

P1476

Chronic pancreatitis and syste ...... se model of pancreatic cancer.

@en

P2093

Christoph Hudemann

http://www.w3.org/2001/XMLSchema#string

Detlef K Bartsch

http://www.w3.org/2001/XMLSchema#string

Jens Waldmann

http://www.w3.org/2001/XMLSchema#string

Lars Plassmeier

http://www.w3.org/2001/XMLSchema#string

Matthias Lauth

http://www.w3.org/2001/XMLSchema#string

Moritz Sparn

http://www.w3.org/2001/XMLSchema#string

Volker Fendrich

http://www.w3.org/2001/XMLSchema#string

P2860

STATs in cancer inflammation and immunity: a leading role for STAT3

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer.

Hedgehog inhibition with the orally bioavailable Smo antagonist LDE225 represses tumor growth and prolongs survival in a transgenic mouse model of islet cell neoplasms.

Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.

Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate.

P304

463-470

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEO.2014.05.010

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Richard F Knoop

P577

2014-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263323239

http://www.w3.org/2001/XMLSchema#string

P698

24953430

http://www.w3.org/2001/XMLSchema#string

P921

P932

4198747

http://www.w3.org/2001/XMLSchema#string